Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide to accelerate union of comminuted tibial and femoral shaft fractures
IRCT20221220056874N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of teriparatide in tibial diaphyseal fracture and Femoral diaphyseal fracture, sponsored by Alborz University of Medical Sciences. Started Feb 2023; status: completed.
02
Drugs
teriparatide
03
Conditions
tibial diaphyseal fractureFemoral diaphyseal fracture
Beyond the preview
Go deeper on IRCT20221220056874N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221220056874N1.